22-10-2009 MeVis Medical Solutions awarded with Deloitte Technology Fast 50 Award 2009

Bremen, October 22, 2009 – MeVis Medical Solutions AG [ISIN: DE000A0LBFE4], a software specialist for medical imaging, announced today its Deloitte Technology Fast 50 nomination, which indicates the ranking of the fastest growing technology companies in Germany. The ranking is based on the cumulative growth rate for the period from 2004 through 2008. During this period the MeVis Group was able to achieve an average growth of 519 percent and was ranked number 16 in this year’s list.

For over ten years now, the MeVis Group has been engaged in research, design, development, and marketing of innovative software solutions for medical imaging, which are consequently focused on epidemiologically significant illnesses. Using MeVis software applications, physicians are able to obtain efficient and reliable evaluations of a broad array of image data derived from different imaging modalities.
This way, MeVis software solutions make a direct contribution to the early detection of cancer diseases such as breast cancer. The clinical orientation is determined in the light of epidemiologically significant illnesses with a focus on early detection, diagnostics, therapy and aftercare for disorders of certain organs. In addition, MeVis provides support for surgery and biopsies.

Breast cancer is the world’s most frequent type of cancer in women. In this segment, the MeVis Group’s extensive breast care applications have attained global market leadership in individual areas with the support of the Company’s industry partners.

MeVis is able to use the expertise gained in this area to broaden its software applications to include other epidemiologically significant diseases such as cancer of the lung, prostate and colon as well as neurological disorders step by step.

The MeVis approach to medical technology is based on various machine-aided examination methods which supply multi-dimensional images of organs, structures and processes within the human body for diagnosing illness-induced changes. This particularly includes X-ray-based processes such as computed tomography and digital mammography and methods like magnetic resonance imaging, which are based on the combination of strong magnetic fields and electromagnetic alternating fields, as well as ultrasoundbased digital sonography. They are supplemented by more recent imaging processes such as positron emission tomography (PET), sono-elastography and molecular imaging.

All MeVis software applications are designed to increase added medical value. MeVis’ core competence lies in the support which it provides for diagnostics, surgery and biopsies as well as the monitoring of therapy progress.

Carl J.G. Evertsz, Ph.D., CEO of MeVis Medical Solutions AG, summarizes the success of the MeVis Group as follows: "With our products we can provide an additional value to medical imaging, because we recognize the valuable momentum from our network of medical experts for the use in the clinical practice and include them in the development of our software applications. We are delighted, that this particular team performance of our 240 employees has received a further recognition with Technology Fast 50 Award from Deloitte."